BIOMAT Database Logo BIOMAT Database Logo

Improvement in the quality of life of patients with rhododendrol-induced leukoderma after camouflaging with dihydroxyacetone cream. 2020

Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D004098 Dihydroxyacetone A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. 1,3-Dihydroxy-2-Propanone,Chromelin,Vitadye,1,3 Dihydroxy 2 Propanone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000440 Butanols Isomeric forms and derivatives of butanol (C4H9OH). Alcohols, Butyl,Butanol,Butylhydroxides,Hydroxybutanes,Butyl Alcohols
D017496 Hypopigmentation A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections. Hypomelanosis,Hypomelanoses

Related Publications

Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
February 2018, International journal of molecular sciences,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma.
March 2015, Journal of dermatological science,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Camouflaging vitiligo with dihydroxyacetone.
August 2008, Dermatology online journal,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
March 2015, Journal of dermatological science,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
August 2019, Journal of dermatological science,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Zebrafish as a new model for rhododendrol-induced leukoderma.
November 2021, Pigment cell & melanoma research,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Rhododendrol-induced leukoderma update I: Clinical findings and treatment.
July 2021, The Journal of dermatology,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Immunohistochemical analysis of rhododendrol-induced leukoderma in improved and aggravated cases.
August 2020, Journal of dermatological science,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
May 2017, The Journal of dermatology,
Kayoko Matsunaga, and Minoru Sasaki, and Takao Okajima, and Masahiro Miyaki, and Hitoshi Sakaguchi
Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
February 2019, Journal of cutaneous pathology,
Copied contents to your clipboard!